Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19
Authors
Keywords
-
Journal
Thrombosis Journal
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-16
DOI
10.1186/s12959-021-00308-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Possible involvement of Syndecan-1 in the state of COVID-19 related to endothelial injury
- (2021) Keiko Suzuki et al. Thrombosis Journal
- An evaluation of venous thromboembolism by whole-body enhanced CT scan for critical COVID-19 pneumonia with markedly rises of coagulopathy related factors: a case series study
- (2021) Fumihiro Ogawa et al. Thrombosis Journal
- A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19)
- (2021) Sajad Karampoor et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Coagulopathy of Coronavirus Disease 2019
- (2020) Toshiaki Iba et al. CRITICAL CARE MEDICINE
- ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019
- (2020) Sara C. Auld et al. CRITICAL CARE MEDICINE
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
- (2020) Songping Cui et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mild or Moderate Covid-19
- (2020) Rajesh T. Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
- (2020) Cynthia Magro et al. Translational Research
- Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans
- (2020) Sharon E Fox et al. Lancet Respiratory Medicine
- The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort
- (2020) Shant Ayanian et al. Biomarkers in Medicine
- COVID-19, coagulopathy and venous thromboembolism: more questions than answers
- (2020) Marco Marietta et al. Internal and Emergency Medicine
- Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
- (2020) Dimitrios Giannis et al. JOURNAL OF CLINICAL VIROLOGY
- The Definition and Risks of Cytokine Release Syndrome in 11 COVID-19-Affected Critically Ill Patients with Pneumonia: Analysis of Disease Characteristics
- (2020) Wenjun Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Coagulation abnormalities and thrombosis in patients with COVID-19
- (2020) Marcel Levi et al. Lancet Haematology
- Serum cholinesterase associated with COVID-19 pneumonia severity and mortality
- (2020) Kento Nakajima et al. JOURNAL OF INFECTION
- Microcirculatory, Endothelial and Inflammatory Responses in Critically Ill Patients with COVID-19 are Distinct from those Seen in Septic Shock
- (2020) Sam D. Hutchings et al. SHOCK
- Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19
- (2020) Masaya Sugiyama et al. GENE
- Factors Enhancing Serum Syndecan-1 Concentrations: A Large-Scale Comprehensive Medical Examination
- (2019) Kazumasa Oda et al. Journal of Clinical Medicine
- Derangement of the endothelial glycocalyx in sepsis
- (2018) Toshiaki Iba et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients
- (2018) Andrea T. Obi et al. Journal of Vascular Surgery-Venous and Lymphatic Disorders
- Endothelial glycocalyx degradation is more severe in patients with non-pulmonary sepsis compared to pulmonary sepsis and associates with risk of ARDS and other organ dysfunction
- (2017) Laura S. Murphy et al. Annals of Intensive Care
- Endothelial glycocalyx layer shedding following lung resection
- (2016) Alexander Arthur et al. Biomarkers in Medicine
- Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases
- (2015) Bernhard F. Becker et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Molecular functions of syndecan-1 in disease
- (2011) Yvonne Hui-Fang Teng et al. MATRIX BIOLOGY
- Thrombotic risk factors: Basic pathophysiology
- (2010) Ida Martinelli et al. CRITICAL CARE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now